We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Typically responds within one business day.
Investments in securities markets are subject to market risks. Read all the related documents carefully before investing. Past performance is not indicative of future returns.
Disclaimer
Past performance is not indicative of future returns. All returns are TWRR based. Investments in securities markets are subject to market risks. Read all the related documents carefully before investing.
Investments in securities markets are subject to market risks. Read all the related documents carefully before investing. Past performance is not indicative of future returns.
Share a few details and our advisory team will walk you through the next steps.
Read InCred Asset Management’s story and investment philosophy on the firm page.
View InCred Asset Management
Virendra Kumar
FMFund Manager, Hedge Fund Strategies
Aditya Khemka
FMFund Manager – Healthcare, InCred Asset Management
Aditya Khemka manages InCred's healthcare strategy with 16+ years in healthcare business and investments across US, EU, Latin America, and India. Previously at DSP Investment Managers, where the DSP Healthcare Fund was the best-performing sectoral fund. Career: Glenmark Pharma (Brazil/Argentina) → Lehman Brothers (US generics coverage) → Nomura UK (MNC pharma: GSK, Novartis, Sanofi) → Nomura India (Indian healthcare coverage from 2011) → DSP → InCred.
Bhupinder Singh
Founder & Group CEO, InCred
Saurabh Jhalaria
CIO, Alternative Credit Strategies
Vivek Singla
Managing Partner & CIO, Private Equity
Ankur Jain
Managing Director, Private Credit Strategies
Registration No
INP000007410
Fund Manager
Mr.Aditya Khemka
Compliance Officer
Mr.Dhawal Mehta
Principal Officer
Mr.Aditya Khemka
Inflow
₹0.25 Cr
Outflow
₹4.04 Cr
Net
₹-3.79 Cr
Not reported — complaint data for this strategy isn't available yet.
Share a few details and our advisory team will walk you through the next steps.
Last updated: 1 Oct 2025
Be the first to discuss InCred Small and Midcap Portfolio — share your research, ask questions, or compare notes with other investors.